EVALUATION OF SLOW RELEASE NICARDIPINE IN ESSENTIAL-HYPERTENSION BY CASUAL AND AMBULATORY BLOOD-PRESSURE MEASUREMENTS - EFFECTS OF ACUTE VERSUS CHRONIC ADMINISTRATION

被引:22
作者
BELLET, M
PAGNY, JY
CHATELLIER, G
CORVOL, P
MENARD, J
机构
关键词
D O I
10.1097/00004872-198710000-00015
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
引用
收藏
页码:599 / 604
页数:6
相关论文
共 25 条
[1]   COMPARISON OF ANTIHYPERTENSIVE AND HORMONAL EFFECTS OF A CARDIOSELECTIVE BETA-BLOCKER, ACEBUTOLOL, AND DIURETICS IN ESSENTIAL HYPERTENSION [J].
ALHENCGELAS, F ;
PLOUIN, PF ;
DUCROCQ, MB ;
CORVOL, P ;
MENARD, J .
AMERICAN JOURNAL OF MEDICINE, 1978, 64 (06) :1005-1012
[2]   1ST-STEP TREATMENT OF MILD TO MODERATE UNCOMPLICATED ESSENTIAL-HYPERTENSION BY A NEW CALCIUM-ANTAGONIST - NICARDIPINE [J].
BELLET, M ;
LORIA, Y ;
LALLEMAND, A .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1985, 7 (06) :1149-1153
[3]   MONITORING 24-HOUR BLOOD-PRESSURE IN A DRUG TRIAL - EVALUATION OF A NONINVASIVE DEVICE [J].
BERGLUND, G ;
DEFAIRE, U ;
CASTENFORS, J ;
ANDERSSON, G ;
HARTFORD, M ;
LIEDHOLM, H ;
LJUNGMAN, S ;
THULIN, T ;
WIKSTRAND, J .
HYPERTENSION, 1985, 7 (05) :688-694
[4]   TISSUE-RESPONSE SELECTIVITY OF CALCIUM-ANTAGONISTS IS NOT DUE TO HETEROGENEITY OF [NITRENDIPINE-H-3 BINDING-SITES [J].
BRISTOW, MR ;
GINSBURG, R ;
LASER, JA ;
MCAULEY, BJ ;
MINOBE, W .
BRITISH JOURNAL OF PHARMACOLOGY, 1984, 82 (02) :309-320
[5]   REVIEW OF THE CARDIOVASCULAR ADVERSITY OF THE CALCIUM-ANTAGONIST BETA-BLOCKER COMBINATION - IMPLICATIONS FOR ANTIHYPERTENSIVE THERAPY [J].
BROUWER, RML ;
FOLLATH, F ;
BUHLER, FR .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1985, 7 :S38-S44
[6]  
BUHLER FR, 1983, HYPERTENSION, V5, P94
[7]   EFFECTS OF THE ANGIOTENSIN CONVERTING ENZYME-INHIBITOR, CAPTOPRIL, IN ESSENTIAL-HYPERTENSION [J].
CAMPBELL, BC ;
SHEPHERD, AN ;
REID, JL .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 13 (02) :213-217
[8]   INTER-SUBJECT AND INTRA-SUBJECT VARIATION IN THE 1ST-PASS ELIMINATION OF HIGHLY CLEARED DRUGS DURING CHRONIC DOSING - STUDIES WITH DEUTERATED VERAPAMIL [J].
EICHELBAUM, M ;
SOMOGYI, A .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 26 (01) :47-53
[9]  
FERLINZ J, 1982, LANCET, V1, P624
[10]  
GOULD BA, 1981, LANCET, V2, P1377